Diabetes Treatment

Overdose cure hands lifeline to thousands of diabetic patients

By George ⋅ September 3, 2012 ⋅ Post a comment

Scotsman Overdose cure hands lifeline to thousands of diabetic patientsScotsmanProfessor Sandra MacRury, professor of clinical diabetes at UHI, said: “Patients with type-2 diabetes have an increased risk of all types of vascular disease even when high blood pressure and cholesterol have been treated, and we know that aspirin is …Overdose drug may help diabetes patients, […]

Lexington’s GI Dynamics wins FDA OK for diabetes treatment trial

By George ⋅ August 23, 2012 ⋅ Post a comment

Mass High Tech Lexington's GI Dynamics wins FDA OK for diabetes treatment trialBoston HeraldLexington-based GI Dynamics Inc. said today it has received conditional approval from the U.S. Food and Drug Administration to begin a pivotal clinical trial of its EndoBarrier device to treat patients with Type 2 diabetes, and those who are obese.GI Dynamics gets […]

FDA Approves Lucentis for Treatment of Diabetic Macular Edema; Mylan …

By George ⋅ August 13, 2012 ⋅ Post a comment

AFP FDA Approves Lucentis for Treatment of Diabetic Macular Edema; Mylan …Proactive Investors USA & CanadaGenentech, a member of the Roche Group (PINK:RHHBY), announced Lucentis (ranibizumab injection) was approved by the U.S. Food & Drug Administration for treatment of diabetic macular edema, an eye condition in people with diabetes that causes …FDA approves drug to […]

New Target for Treating Diabetes and Obesity

By George ⋅ August 3, 2012 ⋅ Post a comment

RedOrbit New Target for Treating Diabetes and ObesityScience Daily (press release)Studying mice, they found that when the target protein was disabled, the animals became more sensitive to insulin and were less likely to get fat even when they ate a high-fat diet that caused their littermates to become obese. The findings are …A New Target […]

Bristol Puts Focus on Diabetes Treatment

By George ⋅ July 3, 2012 ⋅ Post a comment

Wall Street Journal Bristol Puts Focus on Diabetes TreatmentWall Street JournalBristol-Myers Squibb hopes to accelerate sales of diabetes drug Bydureon, which Bristol stands to obtain with its proposed purchase of Amylin.Diabetes Treatment: Bristol-Myers Buys Amylin PharmaceuticalsWebProNewsTEXT-Fitch cuts Bristol-Myers Squibb ratingsReutersAhead of the Bell: Amylin Pharma shares climbBusinessweekWorcester Telegramall 443 news articles » More details can be […]

Aggressive pre-diabetes treatment reduces cases of disease: Scientists

By George ⋅ June 13, 2012 ⋅ Post a comment

The Capitol Column Aggressive pre-diabetes treatment reduces cases of disease: ScientistsThe Capitol ColumnA new study recommends an “early and aggressive” approach to treating people with “pre-diabetes” in order to reduce the number of cases of Type 2 diabetes. A recent study, published in the Lancet, suggests that more aggressive pre-diabetes treatment …Sanofi, Novo Nordisk, Amylin […]

Diabetes related deaths are decreasing

By George ⋅ June 3, 2012 ⋅ Post a comment

KSAX Diabetes related deaths are decreasingExaminer.comCarolyne Krupa has posted an article on June 1, 2012 on American Medical News: “What's behind the dramatic decline of diabetes-related deaths.” According to a study published in the June issue of Diabetes Care death rates among individuals with …Diabetes Deaths Drop Substantially, USSouth Asia Mailall 10 news articles » More […]

Double-drug diabetes treatment disappoints in kids

By George ⋅ May 3, 2012 ⋅ Post a comment

International Business Times Double-drug diabetes treatment disappoints in kidsHealthNewsby Gene Emery and Nancy Lapid, Last updated April 30, 2012 NEW YORK (Reuters Health) – In a large new trial looking at ways to slow the progression of type 2 diabetes in children and teens, the addition of a second drug to the mainstay treatment …Aggressive […]

Amylin Pharma rises on report of new sale talks

By George ⋅ April 23, 2012 ⋅ Post a comment

Bloomberg Amylin Pharma rises on report of new sale talksCBS NewsTHE BIG PICTURE: Amylin sells the diabetes treatments Bydureon and Byetta. The company reportedly rejected a buyout offer from Bristol-Myers Squibb Co. earlier this year, and it is being sued by billionaire investor Carl Icahn.Amylin Said to Seek Buyers After Rejecting Bristol-MyersBloombergExclusive: Amylin explores sale, […]

Mouse Study Hints at New Path for Diabetes Treatment

By George ⋅ April 13, 2012 ⋅ Post a comment

The Imperfect Parent Mouse Study Hints at New Path for Diabetes TreatmentPhiladelphia InquirerBy Serena Gordon THURSDAY, April 12 (HealthDay News) — A potential new treatment for type 2 diabetes targets the hormone glucagon instead of insulin, according to a new study in mice. Although the research hasn't yet progressed past animal models of …New study […]

Search